Wockhardt Working On Non-infringing Processes

New Delhi, October 27: | Updated: Oct 28 2002, 05:30am hrs
Aggressively eyeing regulated markets like Europe and US, leading pharmaceutical company Wockhardt Ltd is developing non-infringing processes for some drugs through biotechnolgy.

We are in the process of developing non-infringing technologies for some products and will enter the European market by 2005, Mr Habil Khorakiwala, chairman, Wockhardt Ltd told PTI here.

The company is investing about Rs 150 crore to set up three facilities near Aurangabad for manufacturing biotech products, he said.

We have invested about Rs. 150 crore to create threefacilities near Aurangabad, two of which are expected to be commissioned by the end of 2003, he said. He said these facilities would specially focus ondvelopment of products for the regulated markets.